New fermentation and purification production technologies for menaquinone-7 for promoting bone and cardiovascular health

我们将开发一种显著更具成本效益和环境友好的生产维生素K(Menaquinone-7，简称MK7)的工艺，以生产人类和动物的食品补充剂。MK7将增加骨骼再生，并将心血管疾病的风险降至最低。它有可能降低社区因这些疾病而付出的代价，并提高澳大利亚老龄化人口的生活质量。骨科疾病也是一个重大的兽医问题，我们的进展应该会使MK7成为马和狗等动物更广泛使用的补充食物。

We will develop a significantly more cost-efficient and environmentally friendly process for the production of vitamin K (menaquinone-7, or MK7) to manufacture food supplements for humans and animals. MK7 will increase bone regeneration and minimise the risk of cardiovascular disease. It has the potential to reduce the costs of these conditions for the community, and to increase the quality of life for Australia's ageing population. Orthopaedic diseases are also a major veterinary issue, and our advance should make MK7 a more widely used available supplementary food for animals such as horses and dogs.